|
The Effect of RF Genicular Nerve Block Applied in the Preoperative Period on Fast-track Total Knee Arthroplasty
RECRUITINGSponsored by Pamukkale University
Actively Recruiting
SponsorPamukkale University
Started2023-10-19
Est. completion2024-05-30
Eligibility
Age40 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06239649
Summary
In our study, investigators plan to compare the preoperative RF and genicular nerve ablation approach in patients who underwent TKA(Total Knee Arthroplasty) using the Fast-Track protocol in terms of meeting postoperative pain, function and early discharge criteria.
Eligibility
Age: 40 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria: * Being between the ages of 40 and 85, * Being able to understand verbal and written information given in Turkish, * Being able to speak and understand Turkish, * Being subjected to unilateral TKA surgery due to the diagnosis of Primary Knee osteoarthritis Exclusion Criteria: * Patients planned for revision knee prosthesis surgery, * Patients previously diagnosed with psychiatric disorders, * Patients who have undergone major surgery on the extremity where TKA will be applied, * Patients with comorbid diseases such as rheumatoid arthritis or cancer, * Patients with a score above 3 according to the American Society of Anesthesiologists (ASA) scoring, * Patients with neurological diseases that cause functional disability, * Patients with flexion limitation of more than 45 degrees and extension limitation of more than 20 degrees, * Patients who have to use hypnotic or anxiolytic drugs regularly, * Patients with alcohol or drug addiction, * Patients with bleeding disorders * Patients with uncontrolled diabetes
Conditions3
ArthritisKnee OsteoarthritisKnee Pain Chronic
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorPamukkale University
Started2023-10-19
Est. completion2024-05-30
Eligibility
Age40 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06239649